Bevacizumab added to chemotherapy, particularly paclitaxel and cisplatin, was efficacious in all response outcomes (objective response, progression-free survival, and overall survival) without diminution in quality of life or unacceptable toxicity.
Although annual screening mammography did increase the detection rate of non-palpable tumors, it did not reduce mortality from breast cancer over 25 years of follow-up.
Compared to cyclic use, a drospirenone-containing oral contraceptive pill used in a continuous fashion after the removal of an endometrioma is associated with a reduction in dysmenorrhea, non-menstrual pelvic pain, and reoccurrence of endometrioma formation.
In recent years, intensive care units (ICUs) have made considerable progress in eliminating central line-associated bloodstream infections (CLABSIs); however, there is still ample room for improvement on infection-control practices in other settings like the ED, where high volumes, patient acuity, crowding, and other factors can interfere with infection-control practices.
